PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 369.00
Bid: 369.00
Ask: 370.00
Change: 7.00 (1.93%)
Spread: 1.00 (0.271%)
Open: 369.00
High: 369.00
Low: 365.00
Prev. Close: 362.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2023 Pillar 3 Disclosures

5 Apr 2024 07:20

RNS Number : 4743J
Bank of Cyprus Holdings PLC
05 April 2024
 

 

Announcement

 

Pillar 3 Disclosures for the year ended 31 December 2023

 

 

Nicosia, 05 April 2024

 

 

 

Bank of Cyprus Holdings Public Limited Company (the "Company" or "BOC Holdings" and, together with its subsidiary, Bank of Cyprus Public Company Limited (the "Bank"), and the Bank's subsidiaries, the "Group"), announces today the publication of its Pillar 3 Disclosures for the year ended 31 December 2023 (the "Pillar 3 Report").

 

A copy of the Pillar 3 Report will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

The Pillar 3 Report is also available on the Group's website www.bankofcyprus.com (Group/Investor Relations).

 

For further information, please contact Investor Relations at investors@bankofcyprus.com.

 

 

Forward Looking Statements

 

This document contains certain forward-looking statements which can usually be identified by terms used such as "expect", "should be", "will be" and similar expressions or variations thereof or their negative variations, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements relating to the Group's near term, medium term and longer term future capital requirements and ratios, intentions, beliefs or current expectations and projections about the Group's future results of operations, financial condition, expected impairment charges, the level of the Group's assets, liquidity, performance, prospects, anticipated growth, provisions, impairments, business strategies and opportunities. By their nature, forward-looking statements involve risk and uncertainty because they relate to events, and depend upon circumstances, that will or may occur in the future. Factors that could cause actual business, strategy and/or results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward-looking statements made by the Group include, but are not limited to: general economic and political conditions in Cyprus and other European Union (EU) Member States, interest rate and foreign exchange fluctuations, legislative, fiscal and regulatory developments, information technology, litigation and other operational risks, adverse market conditions, the impact of outbreaks, epidemics or pandemics and geopolitical developments. This creates significantly greater uncertainty about forward-looking statements. Should any one or more of these or other factors materialise, or should any underlying assumptions prove to be incorrect, the actual results or events could differ materially from those currently being anticipated as reflected in such forward-looking statements. The forward-looking statements made in this document are only applicable as at the date of publication of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in this document to reflect any change in the Group's expectations or any change in events, conditions or circumstances on which any statement is based. Changes in our reporting frameworks and accounting standards, including the recently announced reporting changes and the implementation of IFRS 17 'Insurance Contracts', which may have a material impact on the way we prepare our financial statements and (with respect to IFRS 17) may negatively affect the profitability of Group's insurance business.

 

 

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. At 31 December 2023, the Bank of Cyprus Group operated through a total of 64 branches in Cyprus, of which 4 operated as cash offices. The Bank of Cyprus Group employed 2,830 staff worldwide. At 31 December 2023, the Group's Total Assets amounted to €26.6 bn and Total Equity was €2.5 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCMZGGDVKNGDZG
Date   Source Headline
27th Oct 20237:17 amRNSDate of announcement of 9M2023 FR
24th Oct 202312:41 pmRNSTR1 Notification - Caius
13th Oct 202312:27 pmRNSChanges in the composition of the BODs
27th Sep 20238:28 amRNSDirectorate Change
31st Aug 20237:37 amRNSChanges in the composition of BOD
11th Aug 20239:55 amRNSAppointment of new director
21st Jul 202310:43 amRNSDate of announcement of 1H2023 FR
18th Jul 20234:43 pmRNSIssue of Senior Preferred Notes
3rd Jul 202311:48 amRNSBuyback of Additional Tier 1 Capital Securities
23rd Jun 202312:48 pmRNSComposition of the Boards of Directors
20th Jun 202312:22 pmRNSResults of Additional Tier 1 Tender Cash Offer
19th Jun 202312:34 pmRNSTR1 Notification of Major Holdings - Caius
13th Jun 20233:43 pmRNSRefinancing of AT1 Capital Securities
12th Jun 202311:36 amRNSPDMR Notification of Transaction – Iordanou
12th Jun 20239:40 amRNSLaunch of Cash Tender Offer for AT1 Cap.Securities
12th Jun 20238:39 amRNSPDMR Notification of Transaction – Iordanou
8th Jun 20239:01 amRNSDoc re. (Investor Presentation Update)
8th Jun 20239:00 amRNSAnnouncement for the Investor Update Event
30th May 20237:00 amRNSTR1 Notification of Major Holdings -Eaton Vance
26th May 20235:57 pmRNSResult of AGM-Replacement
26th May 202312:41 pmRNSBoard Election and Board Committees composition
26th May 202312:35 pmRNSResolutions of AGM
16th May 20237:01 amRNSDoc re. (1Q2023 Investor Presentation)
16th May 20237:00 amRNS1Q2023 Group Financial Results
11th May 20238:56 amRNSInvestor Update event scheduled for 8 June 2023
9th May 202312:24 pmRNSAppointment of Additional Corporate Broker
5th May 20239:16 amRNSDate of announcement of 1Q2023 FR
25th Apr 202310:52 amRNSNotice of AGM 2023
19th Apr 20237:06 amRNSTR1 Notification of Holdings -Eaton Vance
13th Apr 20231:44 pmRNSResumption of dividend payments
5th Apr 202311:51 amRNSDoc re. (2022 Pillar 3 Disclosures)
3rd Apr 202310:07 amRNSChanges in the composition of the Boards
31st Mar 202312:54 pmRNSBOC Annual Financial Report 2022 Announcement
31st Mar 202312:50 pmRNSBOCH Annual Financial Report 2022 Announcement
31st Mar 202312:49 pmRNSFY2022 Group Financial Results
31st Mar 202312:46 pmRNSDoc re. (FY2022 Investor Presentation)
21st Mar 202311:02 amRNSDate of announcement of the Audited FR FY2022
20th Feb 202312:12 pmRNSNomination for appoint. to the Board of Directors
20th Feb 20237:04 amRNSPreliminary FY2022 Group Financial Results
20th Feb 20237:02 amRNSDoc re. (Prelim FY2022 Investor Presentation)
8th Feb 20237:04 amRNSAppointment of Additional Corporate Broker
3rd Feb 202310:51 amRNSDate of announcement of PrelimFY2022 FR
9th Jan 20237:00 amRNSTR1 Notification of Major Holdings -Senvest
30th Dec 20227:33 amRNSLong Term Incentive Plan
23rd Dec 20229:15 amRNSPDMR Notification of Transaction – Iordanou
16th Dec 20221:54 pmRNSExtension of appointment of Group CEO
16th Dec 20228:05 amRNSDate of Annual General Meeting
12th Dec 20227:14 amRNSEU-wide Transparency Exercise 2022
30th Nov 20227:28 amRNSChange in the composition of the Board Committees
25th Nov 20229:36 amRNSPDMR Notification of Transaction – Arapoglou

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.